银屑病患者性功能障碍的初步研究：生物治疗的影响
Pilot study of sexual dysfunction in patients with psoriasis: influence of biologic therapy.
作者信息
Ruiz-Villaverde Ricardo, Sánchez-Cano Daniel, Rodrigo Jesus Ramirez, Gutierrez Carmen Villaverde
机构信息
FEA Dermatología, Complejo Hospitalario de Jaen, Jaen, Spain .
出版信息
Indian J Dermatol. 2011 Nov;56(6):694-9. doi: 10.4103/0019-5154.91831.
BACKGROUND
Psoriasis is a chronic skin disease that affects 1 to 3% of the population in most industrialized countries. It is commonly associated with a variety of psychological problems including low self-esteem, depression, suicidal thoughts, and sexual dysfunction.
MATERIALS AND METHODS
WE HAVE PERFORMED A PILOT STUDY IN WHICH WE HAVE TRIED TO ASSESS THE IMPACT ON SEXUAL DYSFUNCTION IN PATIENTS WITH PSORIASIS WHO HAVE STARTED TREATMENT WITH BIOLOGICAL THERAPY USING VALIDATED INDEXES IN SPANISH: International Index of Erectile Function for men and female sexual function index in women.
RESULTS
Considering the men and women from our study, an improvement in FSFI by an average of 9.5 and 6.3 points is observed, respectively.
CONCLUSION
We considered our series as a first step for a more detailed approach to the study of sexual function in patients with psoriasis.
背景
银屑病是一种慢性皮肤病，在大多数工业化国家，1%至3%的人口受其影响。它通常与多种心理问题相关，包括自卑、抑郁、自杀念头和性功能障碍。
材料与方法
我们开展了一项试点研究，尝试使用西班牙语的有效指标评估开始接受生物疗法治疗的银屑病患者性功能障碍的影响：男性采用国际勃起功能指数，女性采用女性性功能指数。
结果
就我们研究中的男性和女性而言，分别观察到女性性功能指数平均提高9.5分和6.3分。
结论
我们认为我们的系列研究是更详细研究银屑病患者性功能方法的第一步。
Zotero 插件